News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device May 07, 2019
News Industry News FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial May 02, 2019
News Industry News Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases February 26, 2019